JP Stock MarketDetailed Quotes
190A Chordia Therapeutics
- 638
- -28-4.20%
20min DelayTrading Sep 10 13:37 JST
43.05BMarket Cap-20241P/E (Static)
669High624Low655.90KVolume660Open666Pre Close423.17MTurnover93052wk High10.64%Turnover Ratio67.48MShares14252wk Low-31.519EPS TTM3.93BFloat Cap930Historical HighLossP/E (Static)6.16MShs Float142Historical Low-31.519EPS LYR6.76%Amplitude--Dividend TTM12.68P/B100Lot Size--Div YieldTTM
About Chordia Therapeutics Company
Chordia Therapeutics Inc is a bio-venture company specializing in cancer research and development. Its mission is to deliver first-in-class cancer drugs to patients. It is a clinical-stage biotech company engaged in researching and developing novel therapies for cancers with high unmet medical needs.
Company Profile
Symbol190A
Company NameChordia Therapeutics
Founded2017-10-12
MarketTSE Growth
Fiscal Year Ends08-31
Address2-26-1 Muraoka-Higashi Kanagawa
Zip Code251-0012
Phone03-6661-9543
Company Executives
- Name
- Position
- Salary
- Hiroshi Miyake
- Representative Director
- --
- Yukari Nishikata
- Independent Director
- --
- Kousuke Ishii
- Independent Director
- --
- Ayuko Hashimoto
- Independent Director
- --
- Akihiko Shimauchi
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
JP
Overall
Symbol
Latest Price
% Chg